Zucara Therapeutics
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
1
Funding Rounds
$25.0m
Money raised
Funding series
Funding Series Analysis
The company Zucara Therapeutics has raised a total of $25m in funding over 1 rounds.
Key Insights:
- Zucara Therapeutics May 2025 Series B Funding Round: $25m
Zucara Therapeutics May 2025 Series B Funding Round
$25m
Industries
Zucara Therapeutics is active in the following industries: